Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
3.870
-0.100 (-2.52%)
May 6, 2025, 4:00 PM EDT - Market closed
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $100.12 million as of May 6, 2025. Its market cap has decreased by -74.26% in one year.
Market Cap
100.12M
Enterprise Value
-100.45M
1-Year Change
-74.26%
Ranking
Category
Stock Price
3.87
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has decreased from $402.09M to $100.12M, a decrease of -75.10%. That is a compound annual growth rate of -72.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2025 | 102.71M | -72.80% |
| Dec 31, 2024 | 377.64M | -6.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.39B |
| Johnson & Johnson | 375.64B |
| UnitedHealth Group | 364.02B |
| AbbVie | 351.09B |
| Novo Nordisk | 307.48B |
| Abbott Laboratories | 231.09B |
| Novartis AG | 223.50B |
| AstraZeneca | 221.69B |